Grant Initiatives

​Committee on Substance Use and Prevention

-A   +A

​​​​​The AAP ​​​is working on several grants related to substance use.

Maternal-Infant Health and Opioid Use

The American Academy of Pediatrics (AAP) was awarded funding by the Centers of Disease Control and Prevention (CDC), National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), Division of Reproductive Health to improve the quality of care of women of reproductive age and infants exposed to opioid medication. Endorsing the value of collaboration, the AAP has partnered with the American College of Obstetricians and Gynecologists (ACOG) on this project.

The two partner organizations are supportive of improving clinical practice among pediatricians and reproductive primary care providers as indicated in the AAP policy statement, A Public Response to Opioid Use in Pregnancy and ACOG’s Committee Opinion No.711 - Opioid Use and Opioid Use Disorder in Pregnancy. 

As part of the program activities, the two organizations will conduct an environmental scan among key stakeholders, including a needs assessment and gap analysis. Recognizing the abundance of evidence-informed guidance produced in recent years, the collaborative efforts are focused on disseminating and enhancing access to resources on education, screening, prevention, intervention and treatment related to opioid use.

A set of joint principles to address the opioid epidemic, adopted by the AAP, ACOG and other medical organizations revealed that pediatricians and reproductive primary care providers offer opportunities to improve the clinical care for women of reproductive age and infants exposed to opioid medications.

Providers' Clinical Support System—Opioid Therapies (PCSS-O)

Start Date: September 2014
End Date: September 2017

The American Academy of Addiction Psychiatry (AAAP) was awarded this grant from the Substance Abuse and Mental Health Services Administration to train health care professionals to use evidence-based practices in preventing, identifying, and treating opioid dependence. The AAAP is leading a consortium of national professional organizations which includes the AAP. The AAP will be providing pediatricians with 2 educational Webinars per grant year.

To register for future Webinars or to view archived Webinars, click here​.​​​

For more information and resources visit the PCSS-O Web site.

Practice Improvement to Address Adolescent Substance Use - 2 Project (PIAASU-2)

Start Date: January 2019
End Date: December 2021

Supported by the Conrad N. Hilton Foundation, the Practice Improvement to Address Adolescent Substance Use - 2 Project (PIAASU-2) aims to improve the care of adolescents by supporting pediatric practices in adopting best practices for addressing substance use. This project builds upon the previously funded PIAASU project (2014-2018). To reach this goal, the PIAASU-2 project is implementing the following activities: 

  • Periodic Survey of Fellows on substance use (Target date: Fall 2019)

  • AAP Project ECHO® (Extension for Community Health Care Outcomes) Substance Use – a telementoring course aimed at improving pediatricians’ ability to execute the screening, brief intervention, and referral to treatment (SBIRT) approach within the medical home (Target launch date: April 2019) This effort builds on the EQIPP® Substance Use course developed in phase one.

In addition, the project is supporting in part the Pediatrics for the 21st Century (Peds-21) symposium at the 2019 AAP National Conference and Exhibition, Opioids Through the Ages – Caring for Children and Families in the Wake of the Opioid Crisis (October 25, 2019).

NIDAMED Coalition of Healthcare Organizations

Start Date: December 2014
End Date: September 2017

​The National Institute on Drug Abuse, AAP, and 5 other medical professional organizations will be working together to develop a continuing medical education/continuing education program to help train health care clinicians on best practices for addressing substance use disorder with their adolescent patients.

Advertising Disclaimer
            print           email           share